|
1. Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med 2012; 5(6): 485-97. 2. Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol 2000; 25(5): 363-70. 3. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents 2010; 36 Suppl 1: 62-5. 4. Bermarn JD. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24(4): 684–703. 5. Athari A, Jalallu N. Epidemiological survey of cutaneous leishmaniasis in Iran 2001-2005. Sci J Isfahan Univ Med Sci 2006; 24(82): 8–13. [in Persian] 6. Hewaldt BL. Leishmaniasis. Lancet 1999; 354(9185): 1191–9. 7. Moskowitz PF, Kurban AK. Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century. Clin Dermatol 1999; 17(3): 305–15. 8. Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, et al. Leishmaniasis treatment-a challenge that remains: a review. Parasitol Res 2008; 103(1): 1-10. 9. Saldanha AC, Romero GA, Merchan-Hamann E, Magalhães AV, Macedo Vde O. A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety. Rev Soc Bras Med Trop 1999; 32(4): 383-7. 10. Kobets T, Grekov I, Lipoldova M. Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem 2012; 19(10): 1443-74. 11. Benmalek Y, Yahia OA, Belkebir B, Fardeau ML. Anti-microbial and anti-oxidant activities of Illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties. Bioengineered 2013; 4(4): 244–8. 12. Djeddi S, Boutaleb H. Evaluation of antioxidative and antibacterial potentials of Crataegus monogyna Jacq. from Mahouna mountain (Algeria). J Advanced Sci Applied Engineering 2014; 1(1): 60-3. 13. Kao ES, Wang CJ, Lin WL, Yin YF, Wang CP, Tseng TH. Anti-inflammatory potential of flavonoid contents from dried fruit of crataegus pinnatifida in vitro and in vivo. J Agric Food Chem 2005; 53(2): 430-36. 14. Shahat AA, Cos P, De Bruyne T, Apers S, Hammouda FM, Ismail SI, , et al. Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica. Planta Med 2002; 68(6): 539-41. 15. Kostic DA, Velickovic JM, Mitic SS, Mitic MN, Randelovic SS. Phenolic Content, and Antioxidant and Antimicrobia Activities of Crataegus Oxyacantha L (Rosaceae) Fruit Extract from Southeast Serbia. Trop J Pharm Res 2012; 11(1): 117-24. 16. Ignat I, Radu DG, Volf I, Pag AI, Popa VI. Antioxidant and antibacterial activities of some natural polyphenols. Cell Chem Technol 2013; 47 (5-6): 387-99. 17. Schüssler M, Hölzl J, Fricke U. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 1995; 45(8): 842-45. 18. Maroufi Y, Ghaffarifar F, Dalimi A, Sharifi Z, Hasan Z. A study on the cytotoxic effect of cantharidin on Leishmania majorpromastigote and amastigote survival in vitro. Feyz 2012; 16(5): 406-13. [in Persian] 19. Maroufi Y, Ghaffarifar F, Dalimi A, Sharifi Z, Hassan Z. Cantharidin-induced apoptosis in Leishmania major promastigotes and macrophages infected by Leishmania major amastigotes in vitro. J Mazandaran Univ Med Sci 2012; 22(89): 32-40. [in Persian] 20. Salmanian S, Sadeghi AR, Alami M, Ghorbani M. Phenolic Content, Antiradical, Antioxidant, and Antibacterial Properties of Hawthorn (Crataegus elbursensis) Seed and Pulp Extract. J Agr Sci Tech 2014; 16(2): 343-54. 21. Asadi M, Bahrami S, Ansari Samani R, Pakniat N. Effect of hydroalcoholic extracts of Stachys lavandulifolia Vahl and Mespilus germanica leaves on Leishmania major. J Med Hormozgan 2012 15(4): 279-84. [in Persian] 22. Shariatifar N, Rahimnia R, Jamshidi AM, Pirali Hamedani M, Shoeibi Sh. Effect of Ethanolic Extract of Mespilus germanica on Cutaneous Leishmaniasis in BALB/c Mice. J Med Plans 2010; 10(39): 76-81. 23. Yousefi R, Ghaffarifar F, Dalimi A. The Effect of Alkanna tincturia and Peganum harmala Extracts on Leishmania major (MRHO/IR/75/ER) in vitro. Iran J Parasitol 2009; 4(1): 40-7.
|
.png){kind=logo}
